O. Odugbesan1, A. Mungmode1, N. Rioles1, D. Buckingham2, M. Scott3, G. Nelson4, R. Hopkins5, A. Grant6, O. Ebekozien

Background and Aims: Multiple cross‐sectional studies have demonstrated lower use of Continuous Glucose Monitors (CGM) in Non‐Hispanic Black (NHB) and Hispanic patients with Type 1 diabetes(T1D). This study is a multicenter trend analysis of ethnic and racial disparities in CGM use

Methods: The T1D Exchange Quality Improvement Collaborative (T1Dx‐QI) identified four endocrinology centers from the learning network to pilot an equity‐focused Quality Improvement study to address disparities in CGM use amongst NHB and Hispanic compared to Non‐Hispanic White (NHW) patients. Retrospective aggregate data from the Electronic Medical Record was reported monthly to the coordinating center. The data were stratified by race and ethnicity. Median values were calculated using Lahey P run charts between Nov 2020 and June 2021. Data were analyzed and plotted on a trend chart

Full study abstract listed under number OP022 / #227 at this link